Inventor · disambiguated record
Shilong Zheng
Also filed as: ZHENG SHILONG
8 granted patents·1 pending application·8 citations·filing 2008–2017
76Inventor score
Files withXAVIER UNIV OF LOUISIANA6THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND1WANG BINGHE1XAVIER UNIVERSITY OF LOUISIANA1
Top patents by PatentIndex Score
9 records- 0174US9353132B2Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancerXAVIER UNIVERSITY OF LOUISIANA·Filed 2013·Granted May 31, 2016·5 cites·41 claims
- 0272US10112962B2Boron-based prodrug strategy for increased bioavailability and lower-dosage requirements for drug molecules containing at least one phenol (or aromatic hydroxyl) groupXAVIER UNIV OF LOUISIANA·Filed 2015·Granted Oct 30, 2018·2 cites·6 claims
- 0361US8653258B2Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteriaWANG BINGHE·Filed 2008·Granted Feb 18, 2014·1 cites·6 claims
- 0451US11098053B2Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cellsTHE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND·Filed 2014·Granted Aug 24, 2021·0 cites·10 claims
- 0550US9650369B2Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative diseaseXAVIER UNIV OF LOUISIANA·Filed 2013·Granted May 16, 2017·0 cites·20 claims
- 0648US11708381B2Inhibitors of androgen receptor signalingXAVIER UNIV OF LOUISIANA·Filed 2017·Granted Jul 25, 2023·0 cites·21 claims
- 0744US11046715B2Boronic derivatives of hydroxamates as anticancer agentsXAVIER UNIV OF LOUISIANA·Filed 2017·Granted Jun 29, 2021·0 cites·19 claims
- 0841US10017475B2Anti-vasculature and anti-tubulin combretastatin analogs for treatment of cancerXAVIER UNIV OF LOUISIANA·Filed 2015·Granted Jul 10, 2018·0 cites·11 claims
- 0939US2019233442A1Selective estrogen receptor down-regulators (serds)XAVIER UNIV OF LOUISIANA·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →